Risk of febrile convulsions in children aged under five years and seasonal influenza vaccines marketed by Pfizer Vaccines
Letter to GPs and PCT immunisation co-ordinators, alerting to a possible increased risk of febrile convulsions in children under five years.
Documents
Details
Letter to GPs and PCT immunisation co-ordinators, alerting to a possible increased risk of febrile convulsions in children under five years of age associated with the use of influenza vaccine marketed by Pfizer Vaccines for the 2010/11 influenza season (Enzira® and CSL Biotherapies generic influenza vaccine)